Drug-induced QTc-interval prolongation in the intensive care unit: Incidence and predictors

Tien M.H. Ng, Keith M. Olsen, Megan A. McCartan, Susan E. Puumala, Katie M. Speidel, Melissa A. Miller, Tom D. Sears

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

There is a paucity of information regarding QTc prolongation in critically ill patients. A prospective observational study was conducted to assess the incidence and predictors of QTc prolongation associated with medications in intensive care unit (ICU) patients. Consecutive adult patients prescribed prespecified QTc-prolonging medications were assessed for development of the combined incidence of QTc >500 ms at anytime and QTc increase >60 ms above baseline. Over 3 months, 200 consecutive patients (63 ± 18 years; 52% female; 73% Caucasian; baseline QTc 447.3 ± 51.5 ms) were evaluated. The primary end point occurred in 48% of the patients (QTc >500 ms 40%, QTc increase >60 ms 29%). The majority of patients experienced a QTc >470 or 450 ms (60.5%). Mean increase in QTc at 48 hours was 20 ± 35 ms. Upon multivariate analysis, length of stay [odds ratio 1.30, 95% confidence interval (1.15, 1.47)] and baseline QTc [1.01 (1.01, 1.02)] were associated with an increased risk for the primary end point, while beta-blockers [0.41 (0.20, 0.81)] were associated with a risk reduction. In conclusion, increased risk of proarrhythmia, as assessed by QTc prolongation, occurs in the majority of ICU patients when prescribed medications with electrophysiologic properties. Increased vigilance is warranted. The possible protective effect of beta-blockers requires confirmation.

Original languageEnglish (US)
Pages (from-to)19-24
Number of pages6
JournalJournal of Pharmacy Practice
Volume23
Issue number1
DOIs
StatePublished - 2010

Fingerprint

Intensive Care Units
Incidence
Pharmaceutical Preparations
Risk Reduction Behavior
Critical Illness
Observational Studies
Length of Stay
Multivariate Analysis
Odds Ratio
Prospective Studies
Confidence Intervals

Keywords

  • Arrhythmia
  • Critical care
  • Drug therapy
  • Drug toxicity
  • Intensive care
  • Torsade de pointes

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Ng, T. M. H., Olsen, K. M., McCartan, M. A., Puumala, S. E., Speidel, K. M., Miller, M. A., & Sears, T. D. (2010). Drug-induced QTc-interval prolongation in the intensive care unit: Incidence and predictors. Journal of Pharmacy Practice, 23(1), 19-24. https://doi.org/10.1177/0897190009356549

Drug-induced QTc-interval prolongation in the intensive care unit : Incidence and predictors. / Ng, Tien M.H.; Olsen, Keith M.; McCartan, Megan A.; Puumala, Susan E.; Speidel, Katie M.; Miller, Melissa A.; Sears, Tom D.

In: Journal of Pharmacy Practice, Vol. 23, No. 1, 2010, p. 19-24.

Research output: Contribution to journalArticle

Ng, Tien M.H. ; Olsen, Keith M. ; McCartan, Megan A. ; Puumala, Susan E. ; Speidel, Katie M. ; Miller, Melissa A. ; Sears, Tom D. / Drug-induced QTc-interval prolongation in the intensive care unit : Incidence and predictors. In: Journal of Pharmacy Practice. 2010 ; Vol. 23, No. 1. pp. 19-24.
@article{5a32e9c4a93647c894a61bde4de5e4d4,
title = "Drug-induced QTc-interval prolongation in the intensive care unit: Incidence and predictors",
abstract = "There is a paucity of information regarding QTc prolongation in critically ill patients. A prospective observational study was conducted to assess the incidence and predictors of QTc prolongation associated with medications in intensive care unit (ICU) patients. Consecutive adult patients prescribed prespecified QTc-prolonging medications were assessed for development of the combined incidence of QTc >500 ms at anytime and QTc increase >60 ms above baseline. Over 3 months, 200 consecutive patients (63 ± 18 years; 52{\%} female; 73{\%} Caucasian; baseline QTc 447.3 ± 51.5 ms) were evaluated. The primary end point occurred in 48{\%} of the patients (QTc >500 ms 40{\%}, QTc increase >60 ms 29{\%}). The majority of patients experienced a QTc >470 or 450 ms (60.5{\%}). Mean increase in QTc at 48 hours was 20 ± 35 ms. Upon multivariate analysis, length of stay [odds ratio 1.30, 95{\%} confidence interval (1.15, 1.47)] and baseline QTc [1.01 (1.01, 1.02)] were associated with an increased risk for the primary end point, while beta-blockers [0.41 (0.20, 0.81)] were associated with a risk reduction. In conclusion, increased risk of proarrhythmia, as assessed by QTc prolongation, occurs in the majority of ICU patients when prescribed medications with electrophysiologic properties. Increased vigilance is warranted. The possible protective effect of beta-blockers requires confirmation.",
keywords = "Arrhythmia, Critical care, Drug therapy, Drug toxicity, Intensive care, Torsade de pointes",
author = "Ng, {Tien M.H.} and Olsen, {Keith M.} and McCartan, {Megan A.} and Puumala, {Susan E.} and Speidel, {Katie M.} and Miller, {Melissa A.} and Sears, {Tom D.}",
year = "2010",
doi = "10.1177/0897190009356549",
language = "English (US)",
volume = "23",
pages = "19--24",
journal = "Journal of Pharmacy Practice",
issn = "0897-1900",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Drug-induced QTc-interval prolongation in the intensive care unit

T2 - Incidence and predictors

AU - Ng, Tien M.H.

AU - Olsen, Keith M.

AU - McCartan, Megan A.

AU - Puumala, Susan E.

AU - Speidel, Katie M.

AU - Miller, Melissa A.

AU - Sears, Tom D.

PY - 2010

Y1 - 2010

N2 - There is a paucity of information regarding QTc prolongation in critically ill patients. A prospective observational study was conducted to assess the incidence and predictors of QTc prolongation associated with medications in intensive care unit (ICU) patients. Consecutive adult patients prescribed prespecified QTc-prolonging medications were assessed for development of the combined incidence of QTc >500 ms at anytime and QTc increase >60 ms above baseline. Over 3 months, 200 consecutive patients (63 ± 18 years; 52% female; 73% Caucasian; baseline QTc 447.3 ± 51.5 ms) were evaluated. The primary end point occurred in 48% of the patients (QTc >500 ms 40%, QTc increase >60 ms 29%). The majority of patients experienced a QTc >470 or 450 ms (60.5%). Mean increase in QTc at 48 hours was 20 ± 35 ms. Upon multivariate analysis, length of stay [odds ratio 1.30, 95% confidence interval (1.15, 1.47)] and baseline QTc [1.01 (1.01, 1.02)] were associated with an increased risk for the primary end point, while beta-blockers [0.41 (0.20, 0.81)] were associated with a risk reduction. In conclusion, increased risk of proarrhythmia, as assessed by QTc prolongation, occurs in the majority of ICU patients when prescribed medications with electrophysiologic properties. Increased vigilance is warranted. The possible protective effect of beta-blockers requires confirmation.

AB - There is a paucity of information regarding QTc prolongation in critically ill patients. A prospective observational study was conducted to assess the incidence and predictors of QTc prolongation associated with medications in intensive care unit (ICU) patients. Consecutive adult patients prescribed prespecified QTc-prolonging medications were assessed for development of the combined incidence of QTc >500 ms at anytime and QTc increase >60 ms above baseline. Over 3 months, 200 consecutive patients (63 ± 18 years; 52% female; 73% Caucasian; baseline QTc 447.3 ± 51.5 ms) were evaluated. The primary end point occurred in 48% of the patients (QTc >500 ms 40%, QTc increase >60 ms 29%). The majority of patients experienced a QTc >470 or 450 ms (60.5%). Mean increase in QTc at 48 hours was 20 ± 35 ms. Upon multivariate analysis, length of stay [odds ratio 1.30, 95% confidence interval (1.15, 1.47)] and baseline QTc [1.01 (1.01, 1.02)] were associated with an increased risk for the primary end point, while beta-blockers [0.41 (0.20, 0.81)] were associated with a risk reduction. In conclusion, increased risk of proarrhythmia, as assessed by QTc prolongation, occurs in the majority of ICU patients when prescribed medications with electrophysiologic properties. Increased vigilance is warranted. The possible protective effect of beta-blockers requires confirmation.

KW - Arrhythmia

KW - Critical care

KW - Drug therapy

KW - Drug toxicity

KW - Intensive care

KW - Torsade de pointes

UR - http://www.scopus.com/inward/record.url?scp=77949352952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949352952&partnerID=8YFLogxK

U2 - 10.1177/0897190009356549

DO - 10.1177/0897190009356549

M3 - Article

C2 - 21507789

AN - SCOPUS:77949352952

VL - 23

SP - 19

EP - 24

JO - Journal of Pharmacy Practice

JF - Journal of Pharmacy Practice

SN - 0897-1900

IS - 1

ER -